Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Search

Reset Filter
You have a filtered search result

51 search results for ‘*’


Business & Regulation Business Practice

The Patent Snatchers

| James Strachan

Can’t offer an “affordable” price? Then say goodbye to market exclusivity.


Discovery & Development Standards & Regulation

Regulatory Action

| Maryam Mahdi

Is the regulator environment changing fast enough to accommodate the vast array of microbiome-based therapeutics beginning to emerge?


Business & Regulation Business Practice

Man Allegedly Praises Pharmaceutical Companies

| Stephanie Sutton

Joe Biden apparently dared say there were “great drug companies out there – except for a couple of opioid outfits.”

Business & Regulation Supply Chain

A Whole Hog of Problems

| Maryam Mahdi

Six members of the US's congress demand answers from the FDA as the risk of heparin shortages loom.

Discovery & Development Formulation

Get your Coat!

| Maryam Mahdi

Researchers at the University of Bath have developed a technique which could prevent drugs from spoiling.

Discovery & Development Clinical Trials

Of Men and Mice

| James Strachan

Male animal bias in preclinical research isn’t scientifically justified and may be skewing our understanding of the brain.

Discovery & Development Clinical Trials

Choice Matters

| Maryam Mahdi

A new vaccine could help give people at risk of HIV more options.

Discovery & Development Drug Delivery

Long Lasting Relief

| Maryam Mahdi

Innovation in the ENT space is lacking. Lyra Therapeutics is, therefore, trying to create solutions for patient with unmet clinical needs.

Business & Regulation Business Practice

GDUFA 2020

| Stephanie Sutton

GDUFA fees for 2020 have been decided – and include a significant drop in the fees for finished dosage facilities.

Business & Regulation Trends & Forecasts

Inside the World’s Most Expensive Pharmaceutical Market

| Maryam Mahdi

As US prices for Rx drugs continues to rise, patients are finding themselves priced out of access to much-needed medicines.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register